• Controversial Legal or Ethical Issues - Newborn Screening and Early Discharge of Mothers and Newborns (Southeastern Regional Genetics Group
  Winter 1996 Newsletter)
• Evaluation of Genetic Testing - Newborn Screening Quality Assurance (Chapter 13, Genetics and Public Health in the 21st Century, Center for Disease Control, 1999)
• Expanded Newborn Screening: Lessons Learned from MCAD deficiency (Peadiatrics & Child Health, Vol. 9 No. 4, April 2004)
• Newborn Screening for Sickle Cell Disease Update -- California, Illinois, and New York 1998 (Center for Disease Control and Prevention, August 18, 2000)
• Newborn Screening for sickle cell disease: A 1998-2003 Quebec experience, (Peadatrics and Child Health - The Official Journal of The Canadian Paedatric Society, April 200, Volume 11, Number 4: 223-227)
• Overview of Newborn Screening Practices in Canada - Presentation by Dr. P. Chakraborty (November 17, 2005)
• Newborn Screening for Cystic Fibrosis: Evaluation of Benefits and Risks and Recommendation for State Newborn Screening Programs (Center for Disease Control and Prevention, October 15, 2004)
• Newborn Screening for Medium Chain Acyl~CoA Dehydrogenase Deficiency Using Tandem Mass Spectrometry: Clinical and Cost-effectiveness (Technology Report, Issue 62, March 2006)
• Newborn Screening for Duchenne Muscular Dystrophy Workgroup: Lay Report (Center for Disease Control and Prevention, 2004)
• Newborn screening with tandem mass spectrometry: 12 months' experience in NSW Australia (Acta pediatrica, December 1999)
• Newborn Screening Report Addresses Inconsistencies and Controversies (American Academy of Pediatrics, August 2000)
• Newborn Screening Tests (About Kids Health, September 2005)
• Newborn Screening in Canada - Are we out of Step (Dr. William B. Hanley, Peadiatrics & Child Health, Vol. 10 No. 4, April 2005)
• Screening for Hemoglobinophathies in Canada (Canadian Task Force on Preventative Health Care, 1994)
• The Canadian Paediatric Surveillance Program: A new opportunity to help shape public health policy- Editorial (Peadiatrics & Child Health, Vol. 6 No. 5, June 2001)
• The epidemiology of medium chain acyl-CoA dehyrodgenase definciency: An update ( Center for Disease Control, Vol. 8, No. 4, April 2006)
• Top Ten Pitfalls in NBS (Genetic Drift, Vol 15. Winter, 1998)
• Using Tandem Mass Spectrometry for Metabolic Disease Screening Among Newborns (Center for Disease Control and Prevention, April 13, 2001)

Newborn Screening Legal Issues

• Screening of Newborns for Genetic and Metabolic Disorders — The Issue of Parental Choice (ISUMA, Vol. 2, Autumn 2001)
• Newborn Screening, Banking and Consent (GenEdit, 2004)
• Privacy and rights issues related to developments in health genetics: Highlights of recent legal and policy research at the Department of Justice Canada (DOJ).
  

Other Articles of Interest

• Recombinant human acid -glucosidase: Major clinical benefits in infantile-onset Pompe disease - Neurology 2007, Vol. 6; pages:99-109
• SIDS Alliance Pushes For States To Pass Standardized Autopsy And Death Scene Protocols  For Cases Of Sudden, Unexpected Infant Death (Press Release, April 1998)
• Policy and Politics: Newborn Screning gets a Booster in Ontario. (National Medicine Review, Vol 2. No. 17, October 15, 2005)
• The epidemiology of medium chain acyl-CoA dehydrogenase deficiency: an update (Genetics in Medicine: Official Journal of the American College of Medial Genetics, Vol. 8 Issue 6, April 200)
• The Right to be Impatient - Whether the Ministry of Health and Long-term Care has failed to properly administer Newborn Screening in Ontario. Ombudsman Ontario (September 27, 2005)